Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms

Cancer Letters

Volumn 293, Issue 2, 2010, Pages 213-219

  Jordan, Bénédicte F ^a   Peeterbroeck, Julie ^a   Karroum, Oussama ^a   Diepart, Caroline ^a   Magat, Julie ^a   Grégoire, Vincent ^a   Gallez, Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

EPR; MRI; Radiotherapy; S nitrosocaptopril; Tumor

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRIC OXIDE DONOR; OXYGEN; RADIOSENSITIZING AGENT; S NITROSOCAPTOPRIL; DRUG DERIVATIVE; NITRIC OXIDE; S-NITROSOCAPTOPRIL; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD OXYGENATION; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; EXPERIMENTAL NEOPLASM; LIVER TUMOR; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RADIOSENSITIVITY; TUMOR BLOOD FLOW; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; COMPARATIVE STUDY; DRUG EFFECT; HEMODYNAMICS; METABOLISM; RADIATION DOSE; VASCULARIZATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; HEMODYNAMICS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; NEOPLASM TRANSPLANTATION; NITRIC OXIDE; OXYGEN CONSUMPTION; RADIATION TOLERANCE; VASODILATOR AGENTS;

EID: 77952476957     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.01.016     Document Type: Article

References (28)

1. 2 availability on human cancer. Nat. Rev. Cancer 2008, 8:967-975.
2. Rockwell S., Dobrucki I.T., Kim E.Y., Marrison S.T., Vu V.T. Hypoxia and radiation therapy: past history, ongoing research, and future promise. Curr. Mol. Med. 2009, 9:442-458.
3. Bristow R.G., Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat. Rev. Cancer. 2008, 8:180-192.
4. Gallez B., Baudelet C., Jordan B.F. Assessment of tumor oxygenation by electron paramagnetic resonance. principles and applications. NMR Biomed. 2004, 17:240-262.
5. Crokart N., Radermacher K., Jordan B.F., Baudelet C., Cron G.O., Beghein N., Bouzin C., Feron O., Gallez B. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect. Cancer Res. 2005, 65:7911-7916.
6. Crokart N., Jordan B.F., Baudelet C., Cron G.O., Hotton J., Radermacher K., Grégoire V., Beghein N., Martinive P., Bouzin C., Feron O., Gallez B. Glucocorticoids modulate tumor radiation response through a decrease in tumor oxygen consumption. Clin. Cancer Res. 2007, 13:630-635.
7. Ansiaux R., Baudelet C., Jordan B.F., Crokart N., Martinive P., DeWever J., Grégoire V., Feron O., Gallez B. Mechanism of reoxygenation after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor therapy. Cancer Res. 2006, 66:9698-9704.
8. Jordan B.F., Christian N., Crokart N., Grégoire V., Feron O., Gallez B. Thyroid status is a key modulator of tumor oxygenation: implication for radiation therapy. Radiat. Res. 2007, 168:428-432.
9. Jordan B.F., Misson P., Demeure R., Baudelet C., Beghein N., Gallez B. Changes in tumor oxygenation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: monitoring by EPR and MRI. Int. J. Radiat. Oncol. Biol. Phys. 2000, 48:565-570.
10. Jordan B.F., Grégoire V., Demeure R.J., Sonveaux P., Feron O., O'Hara J.A., Vanhulle V.P., Delzenne N., Gallez B. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption. Cancer Res. 2002, 62:3555-3561.
11. Jordan B.F., Beghein N., Aubry M., Grégoire V., Gallez B. Potentiation of radiation-induced regrowth delay by isosorbide dinitrate in FSaII murine tumors. Int. J. Cancer. 2003, 103:138-141.
12. Jordan B.F., Sonveaux P., Feron O., Grégoire V., Beghein N., Dessy C., Gallez B. Nitric oxide as a radiosensitizer: evidence for an intrinsic role in addition to its effect on oxygen delivery and consumption. Int. J. Cancer 2004, 109:768-773.
13. Sonveaux P., Jordan B.F., Gallez B., Feron O. Nitric oxide delivery to cancer: why and how?. Eur. J. Cancer. 2009, 45:1352-1369.
14. Cooke J.P., Andon N., Loscalzo J. S-nitrosocaptopril II. Effects on vascular reactivity. J. Pharmacol. Exp. Ther. 1989, 249:730-734.
15. Taper H.S., Woolley G.W., Teller M.N., Lardis M.P. A new transplantable mouse liver tumor of spontaneous origin. Cancer Res. 1966, 26:143-148.
16. Gallez B., Jordan B.F., Baudelet C., Misson P.D. Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry. Reson. Med. 1999, 42:627-630.
17. 19F magnetic resonance imaging: simultaneous comparison with fluorescence quenching. Magn. Reson. Med. 2009, 61:634-638.
18. Sersa G., Cemazar M., Miklavcic D., Chaplin D.J. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res. 1999, 19:4017-4022.
19. Ansiaux R., Baudelet C., Jordan B.F., Beghein N., Sonveaux P., De Wever J., Martinive P., Grégoire V., Feron O., Gallez B. Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin. Cancer. Res. 2005, 11:743-750.
20. Tsuchiya K., Jiang J.J., Yoshizumi M., Tamaki T., Houchi H., Minakuchi K., Fukuzawa K., Mason R.P. Nitric oxide-forming reactions of the water-soluble nitric oxide spin-trapping agent, MGD. Free Radical Biol. Med. 1999, 27:347-355.
21. Jordan B.F., Christian N., Crokart N., Grégoire V., Feron O., Gallez B. Thyroid status is a key modulator of tumor oxygenation: implication for radiation therapy. Radiat. Res. 2007, 168:428-432.
22. Clementi E., Brown G.C., Foxwell N., Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc. Natl. Acad. Sci. USA 1999, 96:1559-1562.
23. Attoub S., Gaben A.M., Al-Salam S., Al Sultan M.A., John A., Nicholls M.G., Mester J., Petroianu G. Captopril as a potential inhibitor of lung tumor growth and metastasis. Ann. NY. Acad. Sci. 2008, 1138:65-72.
24. De S., la Iglesia Iñigo C.E., López-Jorge M.T., Gómez-Casares A., Lemes Castellano P., Martín Cabrera J., López Brito A., Suárez Cabrera T., Labarta Molero. Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents. Leuk. Res. 2009, 33:810-816.
25. Buga G.M., Ignarro L.J. Nitric oxide and cancer. Nitric Oxide Biology and Pathobiology 2000, 895-920. Academic Press, London. L.J. Ignarro (Ed.).
26. Jia L., Pei R., Lin M., Yang X. Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities. Food Chem. Toxicol. 2001, 39:1135-1143.
27. Jordan B.F., Beghein N., Crokart N., Baudelet C., Grégoire V., Gallez B. Preclinical safety and antitumor efficacy of insulin combined with irradiation. Radiother. Oncol. 2006, 81:112-117.
28. Juggi J.S., Koenig-Berard E., Vitou P. Vasodilator therapy: interaction of nitrates with angiotensin-converting enzyme inhibitors. Can. J. Cardiol. 1991, 7:419-425.